SWATH proteomic analysis from the standard care versus celecoxib outcome trial identifies renal biomarkers are associated with early cardiovascular events amongst NSAID users
Event:
ESC Congress 2022
Topic:
Biomarkers
Session:
Clinical and basic science insights in vascular disease
